Evaluation of effect of clonidine in the value of bleeding during surgery

Evaluation of effect of clonidine during bimaxillary osteotomy surgery in shariati hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012102811293N1

Enrollment

Registered

2013-07-16

Start date

2011-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthognathic Bimax Surgery. Major anomalies of jaw size

Interventions

oral Clonidine as intervention and placebo in control group 3µg/kg.

oral Clonidine as intervention and placebo in control group 3µg/kg..

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria:the patients who have the history of using long term corticostroid ;the coagulant drugs;the activator of autonomic system should excluded. inclusion criteria:the patients with 18 -60 years old candidate for orthognathic bimax with personal costent

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The volume and intensity of bleeding. Timepoint: per 10 minutes. Method of measurement: The amount of acculamtion of blood in surgical suction (cc).	—

Secondary

Measure	Time frame
The volume of recieving of liquid IV during surgery. Timepoint: Per 10 minute. Method of measurement: cc/check list.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArmita Arvin

Craniomaxillofacial Research Center

armita85@yahoo.com+98 21 8490 2473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026